Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.53 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.52 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.52 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.47 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.47 |
| ▸ | GAPDH | P04406 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.46 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.46 |
| ▸ | MMP2 | P08253 | 2/20 | 0.46 |
| ▸ | ATG4B | Q9Y4P1 | 2/20 | 0.46 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.46 |
| ▸ | RAD52 | P43351 | 1/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 1/20 | 0.44 |
| ▸ | ADH1B | P00325 | 1/20 | 0.44 |
| ▸ | ADH1C | P00326 | 1/20 | 0.44 |
| ▸ | ADH1A | P07327 | 1/20 | 0.44 |
| ▸ | ADH4 | P08319 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1786386 | 1.00 | GPR84 (0.53) | GPR84FFAR1FFAR4TRPA1DDAH1 | |
| SCHEMBL1784282 | 1.00 | GPR84 (0.53) | GPR84FFAR1FFAR4TRPA1DDAH1 | |
| SCHEMBL1781773 | 1.00 | GPR84 (0.53) | GPR84FFAR1FFAR4TRPA1DDAH1 | |
| SCHEMBL1783522 | 1.00 | GPR84 (0.53) | GPR84FFAR1FFAR4TRPA1DDAH1 | |
| SCHEMBL5181607 | 1.00 | GPR84 (0.53) | GPR84FFAR1FFAR4TRPA1DDAH1 | |
| SCHEMBL17027541 | 1.00 | GPR84 (0.53) | GPR84FFAR1FFAR4TRPA1DDAH1 | |
| SCHEMBL9324211 | 1.00 | GPR84 (0.53) | GPR84FFAR1FFAR4TRPA1DDAH1 | |
| SCHEMBL21051773 | 1.00 | GPR84 (0.53) | GPR84FFAR1FFAR4TRPA1DDAH1 | |
| SCHEMBL21051774 | 1.00 | GPR84 (0.53) | GPR84FFAR1FFAR4TRPA1DDAH1 | |
| SCHEMBL1784145 | 1.00 | GPR84 (0.53) | GPR84FFAR1FFAR4TRPA1DDAH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3107904-B1 | SUBSTITUTED DELTA-LACTONES AND METHODS OF PREPARING SAME | P2 SCIENCE INC (US) | 2019-06-05 | — | — | EP | claimed |
| US-10011582-B2 | Substituted delta-lactones and methods of preparing same | P2 SCIENCE, INC. (US) | 2018-07-03 | — | — | US | claimed |
| US-20170057940-A1 | SUBSTITUTED DELTA-LACTONES AND METHODS OF PREPARING SAME | P2 SCIENCE, INC. | 2017-03-02 | — | — | US | claimed |
| EP-3107904-A1 | SUBSTITUTED DELTA-LACTONES AND METHODS OF PREPARING SAME | P2 Science, Inc. (US) | 2016-12-28 | — | — | EP | claimed |
| WO-2015126936-A1 | SUBSTITUTED DELTA-LACTONES AND METHODS OF PREPARING SAME | P2 SCIENCE, INC. (US) | 2015-08-27 | — | — | WO | claimed |
| CN-111148739-B | Cyclic peptide antibiotics | 豪夫迈·罗氏有限公司 | 2025-06-03 | — | — | CN | disclosed |
| US-11060079-B2 | Methods and microorganisms for producing flavors and fragrance chemicals | ARDRA INC. (CA) | 2021-07-13 | — | — | US | disclosed |
| US-20190177713-A1 | METHODS AND MICROORGANISMS FOR PRODUCING FLAVORS AND FRAGRANCE CHEMICALS | ARDRA INC. (CA) | 2019-06-13 | — | — | US | disclosed |
| EP-3107904-B1 | SUBSTITUTED DELTA-LACTONES AND METHODS OF PREPARING SAME | P2 SCIENCE INC (US) | 2019-06-05 | — | — | EP | disclosed |
| EP-3107904-B1 | SUBSTITUTED DELTA-LACTONES AND METHODS OF PREPARING SAME | P2 SCIENCE INC (US) | 2019-06-05 | — | — | EP | disclosed |
| EP-3478848-A2 | METHODS AND MICROORGANISMS FOR PRODUCING FLAVORS AND FRAGRANCE CHEMICALS | Ardra Bio Inc. (US) | 2019-05-08 | — | — | EP | disclosed |
| US-10011582-B2 | Substituted delta-lactones and methods of preparing same | P2 SCIENCE, INC. (US) | 2018-07-03 | — | — | US | disclosed |
| US-20110117147-A1 | COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-05-19 | — | — | US | disclosed |
| WO-2009123355-A2 | COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-10-08 | — | — | WO | disclosed |
| EP-1254651-B1 | Use of fragrance retaining composition | TAKASAGO PERFUMERY CO LTD (JP) | 2007-12-12 | — | — | EP | disclosed |
| EP-1254651-A1 | Fragrance retaining composition and use | Takasago International Corporation (JP) | 2002-11-06 | — | — | EP | disclosed |
| US-20020010215-A1 | Clear aqueous ceramide composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-01-24 | — | — | US | disclosed |
| EP-1153595-A2 | Clear aqueous ceramide composition | Takasago International Corporation (JP) | 2001-11-14 | — | — | EP | disclosed |
| US-4774076-A | DENTIFRICES, MOUTHWASHES | LION CORPORATION (JP) | 1988-09-27 | — | — | US | disclosed |
| US-4649044-A | DISCOLORATION INHIBITION | LION CORPORATION (JP) | 1987-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110117147-A1 | COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION | TRPA1, HRH1, HRH2 | GPR84 77/4885FFAR1 229/4885FFAR4 319/4885 |
| US-10011582-B2 | Substituted delta-lactones and methods of preparing same | FASN, EBP, LSS | GPR84 1454/4885FFAR1 99/4885FFAR4 105/4885 |
| US-20170057940-A1 | SUBSTITUTED DELTA-LACTONES AND METHODS OF PREPARING SAME | FASN, EBP, LSS | GPR84 1454/4885FFAR1 99/4885FFAR4 105/4885 |
| US-20020010215-A1 | Clear aqueous ceramide composition | CERS2, CERT1, SGMS1 | GPR84 817/4885FFAR1 50/4885FFAR4 270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.